{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-084955","form_type":"8-K","ticker":"SEM","cik":"0001320414","company_name":"SELECT MEDICAL HOLDINGS CORP","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.579126+00:00","generated_at":"2026-05-31T13:42:07.892700+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Select Medical Q2 revenue up 5.1% to $1.76B, EPS $0.60; Concentra IPO raises $528.8M","bullets":["Q2 rev $1,759.7M (+5.1% YoY), net income $94.8M (+3.2%), GAAP EPS $0.60 vs $0.61 prior.","Adj EBITDA $226.3M (+3.1%); FY2024 guidance reaffirmed (rev $6.9-7.1B, adj EPS $1.96-2.20).","Concentra IPO raised $528.8M (22.5M shares at $23.50); also issued $650M 6.875% Senior Notes due 2032.","IPO & debt proceeds repaid $1.9B of Select credit facilities; $0.125/shr dividend declared."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-084955","json":"https://secwatch.observer/filing/0001104659-24-084955.json","markdown":"https://secwatch.observer/filing/0001104659-24-084955.md","text":"https://secwatch.observer/filing/0001104659-24-084955.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1320414/000110465924084955/0001104659-24-084955-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1320414/000110465924084955/tm2420448d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:42:07.892700+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}